Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.5%

1 terminated/withdrawn out of 22 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
13(92.9%)
Phase 2
1(7.1%)
14Total
N/A(13)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT05355389Not ApplicableRecruiting

Cognitive-motor Telerehabilitation in MS

Role: collaborator

NCT07202195Not ApplicableRecruiting

At Home Use of Stimulation Suits for Managing MS Symptoms

Role: collaborator

NCT06672484Active Not Recruiting

Walking Fatigability and Brain Activity in People With Multiple Sclerosis

Role: collaborator

NCT07175792Recruiting

Accuracy of Motor Performance Perception in Multiple Sclerosis

Role: collaborator

NCT05893225Phase 2Active Not Recruiting

Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration

Role: collaborator

NCT04639401Not ApplicableCompleted

Auditory-motor Coupling in Multiple Sclerosis With Cerebellar Lesions

Role: collaborator

NCT04856384Not ApplicableCompleted

Effect of Variance on Error Correction During Coupling

Role: collaborator

NCT05412043Not ApplicableCompleted

Fatigability in Persons With Multiple Sclerosis: Inputs From Cognition, Walking and Coordination

Role: collaborator

NCT04908891Not ApplicableCompleted

A Comprehensive Assessment of Trunk, Scapula and Upper Limb in Neurological Patients. Reliability, Validity and Interrelatedness

Role: collaborator

NCT06410326Completed

Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological Reserve

Role: lead

NCT05834335Completed

Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment

Role: lead

NCT05408767Completed

Accelerated Brain Volume Loss in People With Multiple Sclerosis

Role: lead

NCT03797937Not ApplicableCompleted

Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II

Role: lead

NCT04538872Not ApplicableCompleted

Learning Strategies for Improving Dual Task Performance in Multiple Sclerosis

Role: collaborator

NCT05003375Unknown

Physiological Responses in Experimentally Induced Cognitive Fatigue in People With Multiple Sclerosis (MS)

Role: collaborator

NCT04929145Completed

The Gut Microbiome in Adult Multiple Sclerosis

Role: lead

NCT04295616Not ApplicableTerminated

Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).

Role: collaborator

NCT03931278Not ApplicableCompleted

Sonification Embodied Associations

Role: collaborator

NCT04158063Not ApplicableCompleted

Cognitive-motor Interference in Persons With MS

Role: collaborator

NCT03860675Not ApplicableCompleted

Assessment of Walking-related Fatigability in Patients With Multiple Sclerosis.

Role: collaborator